Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells

• Published in: Stem cell reports Vol. 17; no. 7; pp. 1636 - 1649
• Main Authors: Gomes, Cátia, VanderWall, Kirstin B, Pan, Yanling, Lu, Xiaoyu, Lavekar, Sailee S, Huang, Kang-Chieh, Fligor, Clarisse M, Harkin, Jade, Zhang, Chi, Cummins, Theodore R, Meyer, Jason S
• Format: Journal Article
• Language: English
• Published: United States Elsevier 12.07.2022
• Subjects: Astrocytes; Cell Cycle Proteins - genetics; Glaucoma - genetics; Humans; Membrane Transport Proteins - genetics; Phenotype; Pluripotent Stem Cells; Retinal Ganglion Cells; autophagy; stem cell; retina; glaucoma; neurodegeneration; astrocyte; retinal ganglion cell
• ISSN: 2213-6711; 2213-6711
• DOI: 10.1016/j.stemcr.2022.05.006

Although the degeneration of retinal ganglion cells (RGCs) is a primary characteristic of glaucoma, astrocytes also contribute to their neurodegeneration in disease states. Although studies often explore cell-autonomous aspects of RGC neurodegeneration, a more comprehensive model of glaucoma should take into consideration interactions between astrocytes and RGCs. To explore this concept, RGCs and astrocytes were differentiated from human pluripotent stem cells (hPSCs) with a glaucoma-associated OPTN(E50K) mutation along with corresponding isogenic controls. Initial results indicated significant changes in OPTN(E50K) astrocytes, including evidence of autophagy dysfunction. Subsequently, co-culture experiments demonstrated that OPTN(E50K) astrocytes led to neurodegenerative properties in otherwise healthy RGCs, while healthy astrocytes rescued some neurodegenerative features in OPTN(E50K) RGCs. These results are the first to identify disease phenotypes in OPTN(E50K) astrocytes, including how their modulation of RGCs is affected. Moreover, these results support the concept that astrocytes could offer a promising target for therapeutic intervention in glaucoma.